1. Home
  2. AWH vs CHNR Comparison

AWH vs CHNR Comparison

Compare AWH & CHNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AWH
  • CHNR
  • Stock Information
  • Founded
  • AWH 1993
  • CHNR N/A
  • Country
  • AWH United States
  • CHNR Hong Kong
  • Employees
  • AWH N/A
  • CHNR N/A
  • Industry
  • AWH Medical/Dental Instruments
  • CHNR Precious Metals
  • Sector
  • AWH Health Care
  • CHNR Basic Materials
  • Exchange
  • AWH Nasdaq
  • CHNR Nasdaq
  • Market Cap
  • AWH 6.2M
  • CHNR 6.1M
  • IPO Year
  • AWH N/A
  • CHNR 1995
  • Fundamental
  • Price
  • AWH $0.22
  • CHNR $0.57
  • Analyst Decision
  • AWH Buy
  • CHNR
  • Analyst Count
  • AWH 2
  • CHNR 0
  • Target Price
  • AWH $4.40
  • CHNR N/A
  • AVG Volume (30 Days)
  • AWH 298.1K
  • CHNR 43.9K
  • Earning Date
  • AWH 03-27-2025
  • CHNR 01-01-0001
  • Dividend Yield
  • AWH N/A
  • CHNR N/A
  • EPS Growth
  • AWH N/A
  • CHNR N/A
  • EPS
  • AWH N/A
  • CHNR N/A
  • Revenue
  • AWH $8,963,000.00
  • CHNR N/A
  • Revenue This Year
  • AWH $11.87
  • CHNR N/A
  • Revenue Next Year
  • AWH $79.10
  • CHNR N/A
  • P/E Ratio
  • AWH N/A
  • CHNR N/A
  • Revenue Growth
  • AWH N/A
  • CHNR N/A
  • 52 Week Low
  • AWH $0.21
  • CHNR $0.51
  • 52 Week High
  • AWH $4.47
  • CHNR $1.43
  • Technical
  • Relative Strength Index (RSI)
  • AWH 21.26
  • CHNR 43.80
  • Support Level
  • AWH $0.21
  • CHNR $0.55
  • Resistance Level
  • AWH $0.36
  • CHNR $0.60
  • Average True Range (ATR)
  • AWH 0.06
  • CHNR 0.03
  • MACD
  • AWH -0.00
  • CHNR -0.00
  • Stochastic Oscillator
  • AWH 4.76
  • CHNR 28.57

About AWH Aspira Women's Health Inc.

Aspira Womens Health Inc is engaged in developing and commercializing diagnostic tests for gynecologic diseases. Its products include OvaSuite which is a portfolio of blood tests that applies proprietary algorithms incorporating patient features; OvaWatch intended for use in assessing the risk of ovarian cancer for women with adnexal masses; and Ova1Plus is a portfolio of blood tests, Ova1Plus is a combination of two FDA-cleared tests for women with pelvic masses who are planned for surgery.

About CHNR China Natural Resources Inc.

China Natural Resources Inc is an investment holding company. It principally engaged in the exploration and mining and wastewater treatment businesses in the People's Republic of China. The company has two operating segments: (i) Wastewater treatment segment, which consists of sales of assembled equipment, provision of construction service, and participation in PPP projects as an operator (ii) Exploration and mining segment, which consists of the exploration of lead, silver, and other metals in the Inner Mongolia Autonomous Region of the PRC and the trading of copper ores products. It earns the majority of its revenue from the Wastewater treatment segment.

Share on Social Networks: